Tracey McCain
Compliance Officer bei BLUEPRINT MEDICINES CORPORATION
Vermögen: 6 Mio $ am 30.04.2024
Aktive Positionen von Tracey McCain
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06.09.2016 | - |
| General Counsel | 06.09.2016 | - | |
| Unternehmenssekretär | 06.09.2016 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 01.02.2018 | - |
| Independent Dir/Board Member | 01.02.2018 | - |
Karriereverlauf von Tracey McCain
Ehemalige bekannte Positionen von Tracey McCain
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUNOGEN, INC. | Direktor/Vorstandsmitglied | 15.11.2021 | 12.02.2024 |
| Independent Dir/Board Member | 15.11.2021 | 12.02.2024 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | General Counsel | 01.01.2016 | 02.09.2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01.05.1997 | 01.09.2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Ausbildung von Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Tracey McCain
- Erfahrung
